Radiation Oncology

Radiation therapy uses high-energy radiation to damage cancer cells' DNA and destroy their ability to divide and grow. It is delivered using linear accelerators, proton accelerators, metered cobalt-60 exposure, or brachytherapy where radioactive seeds are placed inside the patient on a temporary or permanent basis to kill cancer or relieve pain. The main radiation oncology society and annual conference is the American Society of Radiation Oncology (ASTRO).

RSS icon
Thumbnail

ASTRO 2018: Women receiving weekly breast radiation therapy, daily treatments display similar side effects 

Women with early-stage breast cancer who receive large doses of radiation once a week for five weeks will experience the same long-term side effects as women who undergo conventional radiation therapy, according to a ten-year study presented Oct. 21 at the 2018 American Society for Radiation Oncology (ASTRO) annual meeting in San Antonio, Texas.

Thumbnail

ASTRO 2018: African-Americans with prostate cancer respond better to radiation therapy than Caucasian men

Contrary to recent data suggesting African-Americans face a higher mortality risk from prostate cancer than Caucasian men, a new study presented at the 2018 American Society for Radiation Oncology (ASTRO) Annual Meeting suggests African-American men may have higher cure rates when treated with radiation therapy than Caucasian men.

At ASTRO, Siemens Healthineers unveil RT Pro Edition for Biograph Vision for PET/CT radiation therapy planning

RT package of latest PET/CT scanner offers comprehensive therapy planning solution.

Fujifilm announces entry Into U.S. computed tomography market with unveiling of FCT Embrace at ASTRO 2018

World's first 85cm 64 and 128 slice wide bore CT unit for oncology

Thumbnail

ASTRO, industry leaders issue new radiation treatment guidelines for early-stage prostate cancer

Prominent medical societies have issued new clinical guidelines, Thursday, Oct. 11, recommending physicians use external beam radiation therapy (EBRT) to treat men with early-stage prostate cancer.

Displaying 65 - 69 of 69

Around the web

Cardiovascular Business
GE HealthCare launches new cardiac CT scanner with advanced AI capabilities

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Cardiovascular Business
Bracco updates HeartSee coronary flow capacity software with new diagnostic features

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

Cardiovascular Business
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.